SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-072817
Filing Date
2024-06-18
Accepted
2024-06-18 16:15:39
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417512-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417512-1_4seq1.xml 4 4109
  Complete submission text file 0001104659-24-072817.txt   5599
Mailing Address C/O MARINA BIOTECH, INC. 17870 CASTLETON STREET, SUITE 250 CITY OF INDUSTRY CA 91748
Business Address
Calais Philippe (Reporting) CIK: 0001693728 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40363 | Film No.: 241051976

Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Issuer) CIK: 0001829635 (see all company filings)

IRS No.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)